Vicky Kang

498 total citations · 1 hit paper
12 papers, 315 citations indexed

About

Vicky Kang is a scholar working on Surgery, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vicky Kang has authored 12 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vicky Kang's work include Hormonal and reproductive studies (3 papers), Estrogen and related hormone effects (3 papers) and Prostate Cancer Treatment and Research (3 papers). Vicky Kang is often cited by papers focused on Hormonal and reproductive studies (3 papers), Estrogen and related hormone effects (3 papers) and Prostate Cancer Treatment and Research (3 papers). Vicky Kang collaborates with scholars based in United States, Japan and United Kingdom. Vicky Kang's co-authors include Neal D. Shore, Fred Saad, Ronald Tutrone, Alberto Bossi, Bryan Selby, Daniel J. George, Daniel R. Saltzstein, Michael S. Cookson, Hideyuki Akaza and Xiaolin Fan and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Vicky Kang

11 papers receiving 304 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

2020 259 citations Neal D. Shore, Fred Saad et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vicky Kang United States	5	210	107	62	54	40	12	315
Tom Morris United Kingdom	7	311 1.5×	97 0.9×	67 1.1×	32 0.6×	38 0.9×	11	466
Itsuhiro Takizawa Japan	11	214 1.0×	102 1.0×	59 1.0×	46 0.9×	38 0.9×	26	334
H.K. Tsai United States	3	289 1.4×	146 1.4×	52 0.8×	35 0.6×	71 1.8×	20	401
Abdulla Alhasso United Kingdom	7	125 0.6×	61 0.6×	35 0.6×	47 0.9×	56 1.4×	16	199
M. Bergaglio Italy	12	82 0.4×	91 0.9×	72 1.2×	58 1.1×	223 5.6×	18	396
Julie Huang United States	10	106 0.5×	28 0.3×	91 1.5×	27 0.5×	57 1.4×	19	435
Dianne Lemmon United States	7	308 1.5×	92 0.9×	87 1.4×	60 1.1×	86 2.1×	9	429
Arturo Mendoza-Valdés Mexico	4	170 0.8×	51 0.5×	60 1.0×	27 0.5×	67 1.7×	9	307
Teresa Parli United States	9	279 1.3×	65 0.6×	97 1.6×	26 0.5×	96 2.4×	20	393
Alexandra Leconte France	9	91 0.4×	54 0.5×	65 1.0×	13 0.2×	63 1.6×	30	288

Countries citing papers authored by Vicky Kang

Since Specialization

Citations

This map shows the geographic impact of Vicky Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky Kang more than expected).

Fields of papers citing papers by Vicky Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky Kang. The network helps show where Vicky Kang may publish in the future.

Co-authorship network of co-authors of Vicky Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky Kang. A scholar is included among the top collaborators of Vicky Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky Kang. Vicky Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Reck, Martin, Alicia Okines, Paula R. Pohlmann, et al.. (2021). 557TiP SGNTUC-019: Phase II basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations. Annals of Oncology. 32. S614–S615. 2 indexed citations

Yu, Evan Y., Vicky Kang, Luke Walker, & Matt D. Galsky. (2021). SGNTUC-019: Phase II basket study of tucatinib (TUC) and trastuzumab (Tras) in previously treated solid tumors with HER2 alterations: Urothelial cancer cohort (trial in progress).. Journal of Clinical Oncology. 39(6_suppl). TPS499–TPS499. 1 indexed citations

Pfaff, Miles J., Allison C. Hu, Anthony A. Bertrand, et al.. (2021). Component Restoration in the Bilateral Intermediate Cleft Tip Rhinoplasty. Plastic & Reconstructive Surgery. 148(2). 243e–247e. 3 indexed citations

Monk, Bradley J., Alicia Okines, Paula R. Pohlmann, et al.. (2021). SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations (trial in progress).. Journal of Clinical Oncology. 39(15_suppl). TPS3151–TPS3151. 5 indexed citations

Spratt, Daniel E., Neal D. Shore, Alberto Bossi, et al.. (2020). Relugolix, A Novel Oral GnRH Receptor Antagonist, versus Leuprolide Depot for Prostate Cancer: The HERO Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 108(3). S18–S19. 1 indexed citations

Shore, Neal D., Daniel J. George, Fred Saad, et al.. (2020). HERO phase III trial: Results comparing relugolix, an oral GnRH receptor antagonist, versus leuprolide acetate for advanced prostate cancer.. Journal of Clinical Oncology. 38(15_suppl). 5602–5602. 4 indexed citations

Shore, Neal D., Fred Saad, Michael S. Cookson, et al.. (2020). Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. New England Journal of Medicine. 382(23). 2187–2196. 259 indexed citations breakdown →

Kang, Vicky, Álvaro A. Figueroa, & Russell R. Reid. (2017). Scar Management After Surgical Repair of Lateral Facial Clefts. Journal of Maxillofacial and Oral Surgery. 17(2). 197–200.

Kang, Vicky, et al.. (2017). Myocutaneous Gracilis Free Flaps in Microsurgical Breast Reconstruction: A Systematic Review Comparing Variations of the Upper Gracilis Flap. Journal of Reconstructive Microsurgery. 33(9). 630–635. 3 indexed citations

10.

Kang, Vicky, et al.. (2017). Abstract: Evolution of the Surgical Technique for Direct to Implant Breast Reconstruction: Transitioning from Dual Plane to Pre-Pectoral Implant Placement. Plastic & Reconstructive Surgery Global Open. 5(9S). 109–109. 1 indexed citations

11.

Kang, Vicky, et al.. (2016). Physical Activity in an Underserved Population: Identifying Technology Preferences. Journal of Physical Activity and Health. 14(1). 3–7. 5 indexed citations

12.

Rodby, Katherine A., et al.. (2015). Evaluating Autologous Lipofilling for Parry-Romberg Syndrome–Associated Defects: A Systematic Literature Review and Case Report. The Cleft Palate-Craniofacial Journal. 53(3). 339–350. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact